Evidence map›Paper›PMID 33509040›Full record

ArticleCell cycle (Georgetown, Tex.)2021

MiR-3138 deteriorates the insulin resistance of HUVECs via KSR2/AMPK/GLUT4 signaling pathway.

Yan Chen, Da Lin, Changxuan Shi, Liang Guo, Linhua Liu, Lin Chen, Ting Li, Ying Liu, Chengchao Zheng, Xintong Chi and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yan ChenDepartment of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University , Guangzhou, Guangdong Province, China.
Da LinInstitute of Pharmaceutical Biotechnology and Engineering, College of Biological Science and Biotechnology, Fuzhou University , Fuzhou, Fujian Province, China.
Changxuan ShiInstitute of Pharmaceutical Biotechnology and Engineering, College of Biological Science and Biotechnology, Fuzhou University , Fuzhou, Fujian Province, China.
Liang GuoInstitute of Pharmaceutical Biotechnology and Engineering, College of Biological Science and Biotechnology, Fuzhou University , Fuzhou, Fujian Province, China.
Linhua LiuDepartment of Internal Medicine, South Branch of Fujian Provincial Hospital , Fuzhou, Fujian Province, China.
Lin ChenDepartment of Internal Medicine, South Branch of Fujian Provincial Hospital , Fuzhou, Fujian Province, China.
Ting LiDepartment of Internal Medicine, South Branch of Fujian Provincial Hospital , Fuzhou, Fujian Province, China.
Ying LiuDepartment of Internal Medicine, South Branch of Fujian Provincial Hospital , Fuzhou, Fujian Province, China.
Chengchao ZhengProvincial Clinic Medical College, Fujian Medical University , Fuzhou, Fujian Province, China.
Xintong ChiProvincial Clinic Medical College, Fujian Medical University , Fuzhou, Fujian Province, China.
Chun MengInstitute of Pharmaceutical Biotechnology and Engineering, College of Biological Science and Biotechnology, Fuzhou University , Fuzhou, Fujian Province, China.
Yaoming XueDepartment of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University , Guangzhou, Guangdong Province, China.
Fujian Provincial Hospital · CNFuzhou University · CNFujian Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance (IR) is a complex pathological condition resulting from the dysregulation of cellular response to insulin hormone in insulin-dependent cells and is recognized as a pathogenic hallmark and strong risk factor for metabolic syndrome. The present study aims to elucidate the molecular mechanism of the pathogenesis of IR. Here, we used human umbilical vein endothelial cells (HUVECs) to establish the IR cell model induced by 1 × 10

Indexed as

AMP-Activated Protein KinasesDose-Response Relationship, DrugGlucose Transporter Type 4HumansHuman Umbilical Vein Endothelial CellsInsulinInsulin ResistanceMicroRNAsProtein Serine-Threonine KinasesRNA, Small InterferingSignal TransductionAMP-Activated Protein KinasesGlucose Transporter Type 4InsulinKSR2 protein, humanmicroRNA3138 microRNA, humanMicroRNAsProtein Serine-Threonine KinasesRNA, Small InterferingSLC2A4 protein, humanAMPKGLUT4insulin resistanceKSR2MiR-3138

Identifiers

PMID33509040
PMCPMC7894458
OpenAlexW3122101197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.